adolescents

U.S. FDA Accepts for Review the BLA for MenABCWY

U.S. FDA Accepts for Review the BLA for MenABCWY

2 Comments / Pharmaceuticals /

U.S. FDA Accepts for Review the Biologics License Application (BLA) for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents  Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for its investigational pentavalent meningococcal vaccine candidate (MenABCWY). Pfizer submitted MenABCWY for the prevention of […]

U.S. FDA Accepts for Review the BLA for MenABCWY Read More »

Positive Dupixent Phase 3 results in adults and adolescents with eosinophilic esophagitis 

Positive Dupixent Phase 3 results in adults and adolescents

1 Comment / Pharmaceuticals /

Positive Dupixent Phase 3 results in adults and adolescents with eosinophilic esophagitis  The New England Journal of Medicine has published results from a positive Phase 3 trial showing adults and adolescents treated with Dupixent® (dupilumab) 300 mg weekly experienced significant improvements in signs and symptoms of eosinophilic esophagitis (EoE), which were sustained for up to one year.  EoE is

Positive Dupixent Phase 3 results in adults and adolescents Read More »